These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 32187847)
1. Concordance between TP53 alterations in blood and tissue: impact of time interval, biopsy site, cancer type and circulating tumor DNA burden. Bieg-Bourne CC; Okamura R; Kurzrock R Mol Oncol; 2020 Jun; 14(6):1242-1251. PubMed ID: 32187847 [TBL] [Abstract][Full Text] [Related]
2. Concordance of Genomic Alterations by Next-Generation Sequencing in Tumor Tissue versus Circulating Tumor DNA in Breast Cancer. Chae YK; Davis AA; Jain S; Santa-Maria C; Flaum L; Beaubier N; Platanias LC; Gradishar W; Giles FJ; Cristofanilli M Mol Cancer Ther; 2017 Jul; 16(7):1412-1420. PubMed ID: 28446639 [TBL] [Abstract][Full Text] [Related]
3. Temporal and spatial effects and survival outcomes associated with concordance between tissue and blood KRAS alterations in the pan-cancer setting. Mardinian K; Okamura R; Kato S; Kurzrock R Int J Cancer; 2020 Jan; 146(2):566-576. PubMed ID: 31199507 [TBL] [Abstract][Full Text] [Related]
4. Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer. Wyatt AW; Annala M; Aggarwal R; Beja K; Feng F; Youngren J; Foye A; Lloyd P; Nykter M; Beer TM; Alumkal JJ; Thomas GV; Reiter RE; Rettig MB; Evans CP; Gao AC; Chi KN; Small EJ; Gleave ME J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 29206995 [TBL] [Abstract][Full Text] [Related]
5. Use of Liquid Biopsies in Clinical Oncology: Pilot Experience in 168 Patients. Schwaederle M; Husain H; Fanta PT; Piccioni DE; Kesari S; Schwab RB; Patel SP; Harismendy O; Ikeda M; Parker BA; Kurzrock R Clin Cancer Res; 2016 Nov; 22(22):5497-5505. PubMed ID: 27185373 [TBL] [Abstract][Full Text] [Related]
6. Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer. Vandekerkhove G; Struss WJ; Annala M; Kallio HML; Khalaf D; Warner EW; Herberts C; Ritch E; Beja K; Loktionova Y; Hurtado-Coll A; Fazli L; So A; Black PC; Nykter M; Tammela T; Chi KN; Gleave ME; Wyatt AW Eur Urol; 2019 Apr; 75(4):667-675. PubMed ID: 30638634 [TBL] [Abstract][Full Text] [Related]
7. Survival Implications of the Relationship between Tissue versus Circulating Tumor DNA Rosenberg S; Okamura R; Kato S; Soussi T; Kurzrock R Mol Cancer Ther; 2020 Dec; 19(12):2612-2620. PubMed ID: 32999047 [TBL] [Abstract][Full Text] [Related]
8. Preoperative Circulating Tumor DNA in Patients with Peritoneal Carcinomatosis is an Independent Predictor of Progression-Free Survival. Baumgartner JM; Raymond VM; Lanman RB; Tran L; Kelly KJ; Lowy AM; Kurzrock R Ann Surg Oncol; 2018 Aug; 25(8):2400-2408. PubMed ID: 29948422 [TBL] [Abstract][Full Text] [Related]
9. Clinical correlates of blood-derived circulating tumor DNA in pancreatic cancer. Patel H; Okamura R; Fanta P; Patel C; Lanman RB; Raymond VM; Kato S; Kurzrock R J Hematol Oncol; 2019 Dec; 12(1):130. PubMed ID: 31801585 [TBL] [Abstract][Full Text] [Related]
10. Next-Generation Sequencing of Tissue and Circulating Tumor DNA: The UC San Diego Moores Center for Personalized Cancer Therapy Experience with Breast Malignancies. Shatsky R; Parker BA; Bui NQ; Helsten T; Schwab RB; Boles SG; Kurzrock R Mol Cancer Ther; 2019 May; 18(5):1001-1011. PubMed ID: 30926636 [TBL] [Abstract][Full Text] [Related]
12. High MAF of EGFR mutations and high ratio of T790M sensitizing mutations in ctDNA predict better third-generation TKI outcomes. Li Y; Zhang F; Yuan P; Guo L; Jianming Y; He J Thorac Cancer; 2020 Jun; 11(6):1503-1511. PubMed ID: 32285618 [TBL] [Abstract][Full Text] [Related]
13. Correlation of Somatic Genomic Alterations Between Tissue Genomics and ctDNA Employing Next-Generation Sequencing: Analysis of Lung and Gastrointestinal Cancers. Toor OM; Ahmed Z; Bahaj W; Boda U; Cummings LS; McNally ME; Kennedy KF; Pluard TJ; Hussain A; Subramanian J; Masood A Mol Cancer Ther; 2018 May; 17(5):1123-1132. PubMed ID: 29500272 [TBL] [Abstract][Full Text] [Related]
14. High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program. Park S; Olsen S; Ku BM; Lee MS; Jung HA; Sun JM; Lee SH; Ahn JS; Park K; Choi YL; Ahn MJ Cancer; 2021 Aug; 127(16):3019-3028. PubMed ID: 33826761 [TBL] [Abstract][Full Text] [Related]
15. Analysis of Tissue and Circulating Tumor DNA by Next-Generation Sequencing of Hepatocellular Carcinoma: Implications for Targeted Therapeutics. Ikeda S; Lim JS; Kurzrock R Mol Cancer Ther; 2018 May; 17(5):1114-1122. PubMed ID: 29483209 [TBL] [Abstract][Full Text] [Related]
16. Locus-specific concordance of genomic alterations between tissue and plasma circulating tumor DNA in metastatic melanoma. Calapre L; Giardina T; Robinson C; Reid AL; Al-Ogaili Z; Pereira MR; McEvoy AC; Warburton L; Hayward NK; Khattak MA; Meniawy TM; Millward M; Amanuel B; Ziman M; Gray ES Mol Oncol; 2019 Feb; 13(2):171-184. PubMed ID: 30312528 [TBL] [Abstract][Full Text] [Related]
17. Genomic Profiling of Blood-Derived Circulating Tumor DNA from Patients with Colorectal Cancer: Implications for Response and Resistance to Targeted Therapeutics. Choi IS; Kato S; Fanta PT; Leichman L; Okamura R; Raymond VM; Lanman RB; Lippman SM; Kurzrock R Mol Cancer Ther; 2019 Oct; 18(10):1852-1862. PubMed ID: 31320401 [TBL] [Abstract][Full Text] [Related]
18. Clinical implications of plasma circulating tumor DNA in gynecologic cancer patients. Charo LM; Eskander RN; Okamura R; Patel SP; Nikanjam M; Lanman RB; Piccioni DE; Kato S; McHale MT; Kurzrock R Mol Oncol; 2021 Jan; 15(1):67-79. PubMed ID: 32881280 [TBL] [Abstract][Full Text] [Related]
19. Next-generation sequencing (NGS) of cell-free circulating tumor DNA and tumor tissue in patients with advanced urothelial cancer: a pilot assessment of concordance. Barata PC; Koshkin VS; Funchain P; Sohal D; Pritchard A; Klek S; Adamowicz T; Gopalakrishnan D; Garcia J; Rini B; Grivas P Ann Oncol; 2017 Oct; 28(10):2458-2463. PubMed ID: 28945843 [TBL] [Abstract][Full Text] [Related]
20. Correlation of genomic alterations assessed by next-generation sequencing (NGS) of tumor tissue DNA and circulating tumor DNA (ctDNA) in metastatic renal cell carcinoma (mRCC): potential clinical implications. Hahn AW; Gill DM; Maughan B; Agarwal A; Arjyal L; Gupta S; Streeter J; Bailey E; Pal SK; Agarwal N Oncotarget; 2017 May; 8(20):33614-33620. PubMed ID: 28431395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]